(19)
(11) EP 1 289 539 A1

(12)

(43) Date of publication:
12.03.2003 Bulletin 2003/11

(21) Application number: 01938435.3

(22) Date of filing: 15.06.2001
(51) International Patent Classification (IPC)7A61K 38/05, A61K 9/00
(86) International application number:
PCT/GB0102/613
(87) International publication number:
WO 0109/5925 (20.12.2001 Gazette 2001/51)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 16.06.2000 GB 0014881

(71) Applicant: GLAXO GROUP LIMITED
Greenford, Middlesex UB6 ONN (GB)

(72) Inventors:
  • ARMOUR, Duncan, RobertDiscovery Chemistry
    Sandwich, Kent CT13 9NJ (GB)
  • BROWN, DavidRoche Products Limited
    Hertfordshire AL7 3AY (GB)
  • CONGREVE, Miles, StuartGlaxoSmithKline
    CambridgeCambridgeshire CB2 1EW (GB)
  • GORE, Paul, Martin
    Hertfordshire SG1 2NY (GB)
  • GREEN, Darren, Victor, Steven
    StevenageHertfordshire SG1 2NY (GB)
  • HOLMAN, Stuart
    StevenageHertfordshire SG1 2NY (GB)
  • JACK, Torquil, Iain, Maclean
    StevenageHertfordshire SG1 2NY (GB)
  • MASON, Andrew, McMurtrie
    StevenageHertfordshire SG1 2NY (GB)
  • MORRISS, Karen
    StevenageHertfordshire SG1 2NY (GB)
  • RAMSDEN, Nigel, Grahame
    StevenageHertfordshire SG1 2NY (GB)
  • THOMAS, Marian
    WareHertfordshire SG12 0DP (GB)
  • WARD, Peter
    StevenageHertfordshire SG1 2NY (GB)

(74) Representative: Giddings, Peter John, Dr. et al
GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) PHARMACEUTICAL ANTI-INFLAMMATORY AEROSOL FORMULATION